Antihypertensive and reduced risk for epilepsy, first responders to 9-11 and early dementia risk, FDA approval of donanemab
Neurology Today in 518 Jul 2024

Antihypertensive and reduced risk for epilepsy, first responders to 9-11 and early dementia risk, FDA approval of donanemab

In this week's podcast, Neurology Today's editor-in-chief discusses data on an angiotensin receptor for blocker for hypertension associated with reduced risk for epilepsy, a study finding first responders to 9-11 clean-up sites had an increased risk for early dementia, and dementia experts comment on approval of donanemab.

Episoder(100)

November 4- Issue Introduction

November 4- Issue Introduction

Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the November 4, 2021 issue.

8 Nov 20215min

October 21- Issue Introduction

October 21- Issue Introduction

Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the October 21, 2021 issue.

21 Okt 20215min

October 7- Issue Introduction

October 7- Issue Introduction

Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the October 7, 2021 issue.

7 Okt 20215min

September 16- Issue Introduction

September 16- Issue Introduction

Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the September 16, 2021 issue.

16 Sep 20215min

Populært innen Premium

papaya
krimpodden-vg
giver-og-gjengen-vg
avhort
aftenpodden
storefri-med-mikkel-og-herman
tore-og-haralds-podkast
ida-med-hjertet-i-handen
harm-og-hegseth
tusvik-tnne
big-5-med-nils-og-harald-2
topp-3-med-mads-og-rasmus
konspirasjonspodden
podme-krim
alt-fortalt
fastlegen
aftenpodden-usa
popradet
verdens-verste
catrin-steinar-redder-forholdet